Enliven Therapeutics
ELVN
#3956
Rank
NZ$5.81 B
Marketcap
NZ$79.41
Share price
0.86%
Change (1 day)
127.25%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2026 : NZ$1.06 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is NZ$1.06 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.68 M
2024-12-31N/A-100%
2023-12-31NZ$0.52 M4.13%
2022-12-31NZ$0.5 M118.55%
2021-12-31NZ$0.23 M59.96%
2020-12-31NZ$0.14 M